Anne Borgman
Chief Tech/Sci/R&D Officer at SUTRO BIOPHARMA, INC.
Net worth: 83 359 $ as of 2024-04-29
Profile
Anne E Borgman is currently an Independent Director at NextCure, Inc., a Director at NiKang Therapeutics, Inc., an Independent Director at Curis, Inc., and the Chief Medical Officer at Sutro Biopharma, Inc. She previously worked as the Head-Global Project at Abbott Laboratories, Vice President-Clinical Research & Development at Exelixis, Inc., Chief Medical Officer & Vice President at Humanigen, Inc. and Talon Therapeutics, Inc., a Clinical Associate-Pediatrics at The University of Chicago, and Vice President & Head-Global Therapeutic Area at Jazz Pharmaceuticals Plc.
Dr. Borgman received her undergraduate degree from the University of Illinois and her doctorate from Stritch School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC.
0.03% | 2024-03-04 | 24,374 ( 0.03% ) | 83 359 $ | 2024-04-29 |
NEXTCURE, INC.
-.--% | 2023-06-21 | 0 ( -.--% ) | - $ | 2024-04-29 |
CURIS, INC.
-.--% | 2024-03-24 | 0 ( -.--% ) | - $ | 2024-04-29 |
Anne Borgman active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Director/Board Member | 2021-09-30 |
| CURIS, INC. | Director/Board Member | 2022-09-30 |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-02-27 |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Director/Board Member | 2023-01-17 |
Former positions of Anne Borgman
| Companies | Position | End |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 2022-02-28 |
| EXELIXIS, INC. | Corporate Officer/Principal | 2019-06-30 |
| The University of Chicago | Corporate Officer/Principal | 2009-12-31 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2007-10-31 |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Training of Anne Borgman
| University of Illinois | Undergraduate Degree |
| Stritch School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Health Technology |
| Kalobios Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Anne Borgman
